赵海丰主治医师

科室：内科

擅长：恶性淋巴瘤、多发性骨髓瘤、白血病等的诊断和治疗

简介：赵海丰,男，主治医师，医学博士，讲师。2000-2005天津中医药大学临床医学学士，2005-2010北京协和医学院天津血液学研究所临床医学博士，2010-2011美国新泽西医学院博士后，2011-至今天津医科大学附属肿瘤医院血液肿瘤科主治医师讲师。主要从事恶性肿瘤的化学治疗、分子靶向治疗、造血干细胞移植及中医中药等综合性治疗和个体化治疗。擅长恶性淋巴瘤、多发性骨髓瘤、白血病等的诊断和治疗。
参与国家公益性行业科研专项、国家自然科学基金等多项科研课题，目前承担国家自然基金1项，参编《内科疑难病例血液学分册》1部，在国内外杂志发表中英文论著30篇，其中发表SCI文章10余篇。天津市肿瘤医院新世纪人才，天津市“131”人才。
发表论文
1. Li HY, Zhao HF, Yang RC. Reduced expression of microRNA-409-3p in immune thrombocytopenia. Br J Haematol. 2013;161(1):128-35 (co-first author)
2. Zhao H, Wang D, Du W, Gu D, Yang R. MicroRNA and leukemia: Tiny molecule, great function.Crit Rev Oncol Hematol. 2010;74(3):149-55. (first author)
3. Li HY, Zhao HF, Wang DH, Yang RC. microRNA regulation in the megakaryocytopoiesis. Br J Haematol. 2011;155(3):298-307 (co-first author)
4. Fang zhi, Zhao HF. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of immune thrombocytopenic purpura. Platelets. 2013;24(3):250-2. (Corresponding author)
5. Zhang Y, Zhao D, Zhao H, Wu X, Zhao W, Wang Y, Xia B, Da W. Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis.Med Oncol.2012;29(4):2359-2363 (co-first author)
6. Zhao H, Du W, Wang D, Gu D, Xue F, Ge J, Sui T, Yang R. The expression of IFN-gamma, IL-4, Foxp3 and perforin genes are not correlated with DNA methylation status in patients with immune thrombocytopenic purpura. Platelets. 2010;21(2):137-43. (first author)
7. Zhao H, Du W, Wang D, Gu D, Xue F, Ge J, Sui T, Yang R. Single nucleotide polymorphism in the methyl-CpG binding domain 4 Gene and the risk for immune thrombocytopenic purpura in Chinese population. Platelets. 2010;21(2):132-6. (first author)
8. Zhao H, Du W, Gu D, Wang D, Xue F, Ge J, Sui T, Yang R. DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population. Acta Haematol. 2009;122(1):31-5 (first author)
9. Zhao HF, Li SZ, Yang RC. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets. 2010;21(5):380-5. (first author)
10. Zhang YZ, Zhao HF, Zhao DD,Sun L, Zhao ZG, SDF-1/CXCR4 axis in myelodysplastic syndromes: Correlation with angiogenesis and apoptosis.Leuk Res. 2012, 36(3):281-286.
11. Gu D, Chen Z, Zhao H, Du W, Xue F, Ge J, Sui T, Wu H, Liu B, Lu S, Zhang L, Yang R. Th1 (CXCL10) and Th2 (CCL2) Chemokine Expression in Patients with Immune Thrombocytopenia. Hum Immunol. 2010;71(6):586-91
12. Gu D, Ge J, Du W, Xue F, Chen Z, Zhao H, Zhou Z, Xu J, Liu P, Zhao Q, Zhang L, Yang R. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications. Autoimmunity. 2009;42(8):692-8.
13. Du WT, Zhao HF, Xu JH, Gu DS, Xue F, Ge J, Dong XW, Chen ZP, Zhou ZP, Yang RC. The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum Immunol. 2009;70(6):398-402.
14. Guo ZX, Chen ZP, Zheng CL, Jia HR, Ge J, Gu DS, Du WT, Wang XY, Zhao HF, Yang RC. The role of Th17 cells in adult patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2009;82(6):488-9.
15. Li H, Ge J, Zhao H, Du W, Xu J, Sui T, Ma L, Zhou Z, Qi A, Yang R. Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with idiopathic thrombocytopenic purpura in a Chinese population. Platelets.2011;22(1):37-42.